“…The high worldwide seroprevalence of some of these viruses, such as that of HHV-1 and HHV-2 being around 90% (Wald and Corey, 2007), indicates that facilitating factors must exist that ultimately decide upon disease development. In consideration are comorbidities such as traumas to latently infected neurons (Zhang et al, 2013), immune-depriving conditions such as AIDS (Rodriguez et al, 2020), leukemia (Koskenvuo et al, 2008;Lancman et al, 2020), or stroke-induced immunodepression (Deroux et al, 2012;Hetze et al, 2013;Romer et al, 2015;Bertrand et al, 2019), and cumulative infectious burden (Sico et al, 2015), and also environmental factors (Liu et al, 2013;Brutting et al, 2018;Mueller et al, 2018;Del Re and Giorgi, 2020). The role of aging as a facilitating factor and the interplay with ERVs are discussed in detail below.…”